Ethylene
drugOn this page
Also known as Ethene
Summary
Ethylene (CHEMBL117822) is a phase-3 clinical-stage small-molecule plant hormone; indicated across 2 conditions including acute myocardial infarction.
At a glance
- Status: Max clinical phase 3 (not approved)
- Modality: Small molecule
- Indications: 2 conditions
- Chemistry: 28.05 Da · C2H4
Identifiers
Drug identity and classification
| Field | Value |
|---|---|
| ChEMBL ID | CHEMBL117822 |
| Name | Ethylene |
| Type | Small molecule |
| Max phase | 3 |
| FDA approved | no |
| PubChem CID | 6325 |
| ChEBI | CHEBI:18153 |
| Molecular formula | C2H4 |
| Molecular weight | 28.05 |
| InChIKey | VGGSQFUCUMXWEO-UHFFFAOYSA-N |
SMILES: C=C
IUPAC name: ethene
Other ChEBI roles (chemical / environmental): plant hormone, refrigerant.
Also known as: Ethylene, Ethene, ETHYLENE
Patent coverage: 681,936 distinct patent families (1,645,264 SureChEMBL compound mentions), from 2 matched compound structure(s). One matched structure accounts for 1,631,523 (99%) of the total. Mentions count patents naming the compound (not distinct inventions), so promiscuous / reference molecules inflate the mention figure — families are the dedup metric.
Targets
Targets
No target linkage available.
Bioactivity
No ChEMBL bioactivity rows at pChembl ≥ 5 (expected for biologics / antibodies).
Target pathways
No target-pathway data for this drug (no mapped target genes).
Indications & clinical
Indications
2 indications (0 at ChEMBL trial phase 4). Phase below is the highest clinical-trial phase recorded for this drug against each disease — not the molecule’s overall approval status (that is in the Summary).
| Indication | Trial phase | MONDO | EFO |
|---|---|---|---|
| acute myocardial infarction | 2 | MONDO:0004781 | EFO:0008583 |
1 further indication record had no mapped disease name (EFO/MeSH-only) or were duplicates, and are omitted.
Clinical trials
Total trials: 0.
Clinical evidence (CIViC)
No CIViC predictive evidence (expected for non-precision-medicine drugs).
Pharmacology
Pharmacogenomics
No PharmGKB pharmacogenomic data curated for this drug.
Related molecules
Related molecules
No competitor molecules sharing a primary target (ChEMBL phase ≥2 or PubChem drug-class).
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.